telmisartan has been researched along with Pulmonary Arterial Remodeling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, P; Esfandiarei, M; Milad, N; Rossi, FMV; Sauge, E; Seidman, MA; Tehrani, AY; Theret, M; Tung, LW; van Breemen, C; White, Z; Zhao, RRY | 1 |
| Ding, Y; Dou, F; Li, Y; Liu, T; Liu, W; Mu, F; Shang, P; Sun, L; Wen, A; Zhang, T; Zhang, Y; Zhu, Z | 1 |
2 other study(ies) available for telmisartan and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Pleiotropic activation of endothelial function by angiotensin II receptor blockers is crucial to their protective anti-vascular remodeling effects.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Mice; Nitric Oxide; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Remodeling | 2022 |
Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1.
Topics: Antioxidants; Aorta, Thoracic; Benzimidazoles; Benzoates; Collagen Type I; Fibrosis; Gene Expression Regulation; Hypertension; Oxidants; Oxidative Stress; Reactive Oxygen Species; Smad3 Protein; Telmisartan; Transforming Growth Factor beta1; Vascular Remodeling | 2017 |